edoc

Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature

Zingg, Sandra and Nicoletti, G. Jacopo and Kuster, Sabine and Junker, Milena and Widmer, Andreas and Egli, Adrian and Hinic, Vladimira and Sendi, Parham and Battegay, Manuel and Bättig, Veronika and Khanna, Nina and Tschudin-Sutter, Sarah. (2020) Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature. Open Forum Infectious Diseases, 7 (6). ofaa185.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/77740/

Downloads: Statistics Overview

Abstract

Cefiderocol is a new siderophore cephalosporin with activity against carbapenem-resistant gram-negative bacteria. Data on its clinical efficacy are limited to complicated urinary tract infections. We present a series of 3 patients successfully treated with cefiderocol for complicated health care-associated infections and review published case reports.
Faculties and Departments:03 Faculty of Medicine
03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Infektiologie > Infektionsepidemiologie (Tschudin Sutter)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Infektiologie > Infektionsepidemiologie (Tschudin Sutter)
UniBasel Contributors:Tschudin Sutter, Sarah
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Oxford University Press
e-ISSN:2328-8957
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:28 Dec 2020 11:59
Deposited On:28 Dec 2020 11:59

Repository Staff Only: item control page